ENvue Medical
ENvue Medical is a publicly traded (NASDAQ:FEED) medical device company that develops an FDA-cleared electromagnetic navigation platform for real-time bedside feeding tube placement, selling capital equipment and single-use consumables to hospitals, health systems, and GPOs across the U.S. and UK.
- Company typePublic
- Founded2017
- HeadquartersArlington Heights, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What ENvue Medical does
ENvue Medical is a medical device company that develops, manufactures, and supplies an FDA 510(k)-cleared electromagnetic navigation system for real-time, bedside placement of enteral feeding tubes. The company addresses a clinically meaningful safety problem: approximately 30 million feeding tubes are placed worldwide each year, with 2–5% resulting in lung misplacement and a meaningful pneumothorax risk, generating demand for tools that reduce radiation exposure, repeated X-ray confirmation, and operator-dependent error. The core platform combines an electromagnetic field generator with single-use feeding tubes containing passive sensors, using anatomical landmarks to produce a personalized body map and simultaneous frontal, lateral, and axial visual guidance with airway alerts; clinical studies report zero lung placements across 531 procedures and 96.5% alignment with X-ray confirmation. The portfolio also includes UroShield (NHS-reimbursed catheter-associated UTI device), PainShield (SAW-based pain management), OTC ENFit syringes, and the Ask Oscar AI training platform scheduled for mid-2026 commercial launch.
The company was founded in 2017 in Israel as ENvizion Medical by Doron Besser and Shay Tsuker and was rebranded to ENvue Medical, Inc. (NASDAQ:FEED) in December 2025 following Alpha Capital Anstalt's acquisition of ENvizion's operating assets and IP. Headquarters are in Arlington Heights, Illinois, with R&D centers in Tel Aviv and Nesher, Israel, and a national training academy in Plymouth. Headcount is 11–50 and the operating entity is ENvue Medical (USA) Inc., domiciled in Illinois.
ENvue generates revenue through a razor-and-blade model: one-time capital sales of the ENvue Navigation Platform to hospitals and health systems, complemented by recurring single-use feeding tube consumables per procedure. Go-to-market is enterprise field sales targeting hospital systems, group purchasing organization (GPO) contracts, and standardization deals that embed the platform into clinical workflows; a current GPO renewal covers 90+ hospitals across 17 states. Distribution extends to OTC retail and DME channels for ENFit syringes, and to the UK via an exclusive Peak Medical distribution agreement for UroShield following NHS Drug Tariff Part IX listing. Pricing is quote-based and not publicly disclosed; the company reports a 30% gross margin and a current ratio of 0.86, indicating tight liquidity against an ambitious multi-product expansion agenda.
ENvue Medical firmographics
Firmographics- Name
- ENvue Medical
- Legal name
- ENvue Medical (USA) Inc.
- Website
- https://envuemed.com
- Company type
- Public
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ENvue Medical is a publicly traded (NASDAQ:FEED) medical device company that develops an FDA-cleared electromagnetic navigation platform for real-time bedside feeding tube placement, selling capital equipment and single-use consumables to hospitals, health systems, and GPOs across the U.S. and UK.
- Ownership category
- akta.pro rank
ENvue Medical industry classification
Industry- Product category
- Enteral Feeding Tube Navigation Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
Keywords
Where ENvue Medical is headquartered
LocationHeadquarters
- HQ city
- Arlington Heights
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
ENvue Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Feeding Tube Consumables: Single-use feeding tubes and consumables sold on a recurring basis to hospital customers. The company operates on a recurring revenue model from single-use consumable feeding tubes.
- Capital Equipment Sales: ENvue Navigation Platform capital system sales to hospitals and health systems for bedside feeding tube placement
- AI Training Platform Subscription: Recurring subscription revenue opportunity from 'Ask Oscar' AI training platform expected to be commercially available within months
- OTC ENFit Syringes: Over-the-counter reusable syringes available in 2.5mL, 5mL, 10mL, and 60mL sizes for enteral feeding and medication delivery through retail and DME channels
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | ENvue Navigation Platform - Capital Equipment |
| Unit Pricing | Pay-as-you-go | Single-use Feeding Tubes |
| Unit Pricing | Pay-as-you-go | OTC ENFit Syringes |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels5 records
ENvue Medical product offering
Product offeringCore offering
ENvue Medical develops, manufactures, and supplies the ENvue Navigation Platform—an FDA 510(k)-cleared electromagnetic navigation system that creates patient-specific body maps to guide real-time, bedside placement of enteral feeding tubes. The company also sells disposable ENvue Feeding Tubes with embedded sensors, the Ask Oscar AI clinical training platform, OTC ENFit syringes for enteral medication delivery, and adjacent therapeutic devices including UroShield (catheter care) and PainShield (pain management).
Product overview
ENvue Medical offers a core product portfolio centered on the ENvue Navigation Platform, an FDA 510(k)-cleared electromagnetic feeding tube placement system comprising the electromagnetic field generator, proprietary ENvue Feeding Tubes with built-in sensors, and True Body Navigation technology. The platform provides real-time 3D visualization with simultaneous frontal, lateral, and axial views and alerts for airway proximity. The company supplements this with AI-powered training (Ask Oscar), consumables (ENFit Syringes), and legacy therapeutic devices (UroShield for catheter care, PainShield for pain management). The product ecosystem targets hospitals seeking to modernize enteral feeding tube placement with reduced radiation exposure and improved patient safety.
Differentiator
Problem solved
Functional benefit
Brands
- ENvue System: FDA 510(k)-cleared electromagnetic navigation system for enteral feeding tube placement with real-time body mapping and visualization.
- Ask Oscar
- PainShield
- UroShield
- ENFit Syringes
Products and services
- ENvue Navigation Platform FDA 510(k)-cleared electromagnetic navigation system for real-time, bedside placement of enteral feeding tubes in adult patients, comprising the electromagnetic field generator, proprietary sensor-equipped ENvue Feeding Tubes, and True Body Navigation software that builds a patient-specific body map and provides continuous visual steering in frontal, lateral, and axial views with airway alerts.
- ENvue Feeding Tubes Single-use disposable feeding tubes with built-in passive electromagnetic sensors and ENFit compatibility, used with the ENvue Navigation Platform to enable real-time navigated placement and recurring per-procedure revenue for hospitals.
- Ask Oscar AI-powered training platform that enables clinicians to independently train on ENvue feeding tube navigation without on-site specialists, designed as a recurring subscription offering across existing and prospective hospital customers.
- ENFit Syringes Over-the-counter reusable ISO-standard ENFit syringes for enteral feeding and medication delivery, available in 2.5mL, 5mL, 10mL, and 60mL sizes through online retailers (Amazon), DME suppliers, and non-acute care distribution channels.
- UroShield Therapeutic device using low-frequency ultrasonic energy to reduce catheter-associated urinary tract infections and blockages in patients requiring long-term urinary catheterization in community and hospital settings.
- PainShield Non-invasive therapeutic device using surface acoustic wave technology for pain management applications, retained from the NanoVibronix product line.
Quantifiable outcome
- Zero lung placements across 531 procedures with peer-reviewed clinical evidence
- +6 more outcomes
Companies that use ENvue Medical
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles3 records
ENvue Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature7 records
ENvue Medical partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and flagship.
- U-DelivercoreDistribution agreement to distribute ENvue's over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels. Targets both feeding and medication delivery clinical needs in home care settings.
- Peak MedicalcoreExclusive UK distributor for UroShield Kit. Following NHS Drug Tariff Part IX inclusion enabling nationwide prescription reimbursement, Peak Medical placed an initial purchase order providing early revenue visibility heading into 2026. The partnership supports European expansion and improves patient access in community and hospital settings.
- UK NHSflagshipUroShield Kit added to NHS Drug Tariff Part IX enabling nationwide prescription reimbursement across the United Kingdom. First UK reimbursement approval for the product, removing reimbursement barriers and expanding access across community and hospital settings.
- Group Purchasing Organization (90+ Hospital Health System)flagshipThree-year purchasing agreement renewal providing contracted access to ENvue's Navigation Platform through 2028. Covers over 90 hospitals across 17 states, eliminating facility-level procurement processes. CEO described it as positioning ENvue technology as one clinical decision away from adoption at any participating hospital.
- 12-Hospital Integrated Nonprofit Health System (Virginia and North Carolina)flagshipThree-year contract renewal establishing ENvue Navigation Platform as standardized protocol for bedside feeding tube placement across entire network. Renewal extends commercial relationship through 2028, representing clinical workflow integration rather than mere contracted access.
Scale indicators13 records
Recent moves7 records
Expansion highlights6 records
ENvue Medical competitors and assessment
Company assessmentEmerging players
- AngioDynamics: AngioDynamics is a vascular access and navigation medical device company developing tip-location and navigation technologies for PICC lines and vascular access. ENvue identifies vascular access navigation as an expansion area, placing AngioDynamics as a potential future peer if ENvue extends beyond enteral feeding.
Broad incumbents
- Stryker: Stryker operates in surgical navigation and instrumentation, particularly through its Orthopaedics and Endoscopy segments. While Stryker's navigation offerings focus on orthopedics and neuro rather than enteral, it represents the established surgical navigation category that ENvue's platform paradigm belongs to.
- Brainlab: Brainlab is a leading surgical navigation and digital surgery platform focused on neurosurgery, spine, ENT, and trauma. ENvue's True Body Navigation concept has parallel positioning to Brainlab's patient-specific body mapping approach, though Brainlab specializes in OR-based image-guided surgery rather than bedside enteral placement.
- Smiths Medical: Smiths Medical is a broad medical device incumbent offering enteral feeding products (PORTEX, Medex) and other hospital consumables. ENvue's CMO Fred Reuning previously led marketing for Smiths Medical's vascular access products. Both companies serve hospital enteral care, but Smiths is much broader and does not specialize in navigation.
- Becton, Dickinson and Company (BD): BD is a broad medical device and diagnostics incumbent with significant hospital enteral feeding consumables and vascular access portfolios. BD competes indirectly via traditional non-navigation feeding tubes and related hospital workflow products where ENvue's navigation-enabled consumables compete.
- Medtronic: Medtronic acquired Covidien (which previously acquired super Dimension, ENvue CEO Doron Besser's former employer, for ~$300M). Medtronic's Patient Monitoring & Surgical Solutions divisions compete in adjacent navigation and surgical visualization spaces, providing a benchmark for large medtech scale that ENvue aspires to reach.
Direct peers
- Avanos Medical: Avanos Medical is the most direct competitor through its CORTRAK electromagnetic feeding tube placement system, the historical market leader in enteral navigation. Both companies target the same ICU and bedside feeding tube placement use case, with Avanos offering a deeper installed base and broader commercial reach through its enteral feeding franchise.
- NeoMed: NeoMed specializes in neonatal and pediatric enteral feeding products, directly addressing one of ENvue's identified expansion segments (pediatric/neonatal care). Both companies serve hospital neonatal ICUs with enteral access solutions, and ENvue's VP Commercial previously led North America sales for NeoMed's portfolio at Avanos.
Others
- Cardinal Health: Cardinal Health is a major medical product distributor and GPO operator, relevant because ENvue pursues GPO-driven standardization as a key GTM lever. While not a direct competitor, Cardinal Health's GPO/MedSurg distribution relationships shape the procurement environment in which ENvue competes for hospital contracts.
- Covis Pharma (Nutricia/Danone): Nutricia (part of Danone) is a major enteral nutrition provider whose products are consumed via the feeding tubes ENvue places. While not a navigation competitor, Nutricia sits at the same hospital enteral feeding workflow and represents an adjacent ecosystem partner whose relationships could affect ENvue's hospital adoption dynamics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
ENvue Medical social profiles
Digital presenceENvue Medical compliance and trust
Trust signalCompliance2 records
ENvue Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
ENvue Medical leadership team
Management profileNumber of profiles
Profiles11 records
ENvue Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ENvue Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ENvue Medical
What does ENvue Medical do?
ENvue Medical develops, manufactures, and supplies the ENvue Navigation Platform—an FDA 510(k)-cleared electromagnetic navigation system that creates patient-specific body maps to guide real-time, bedside placement of enteral feeding tubes. The company also sells disposable ENvue Feeding Tubes with embedded sensors, the Ask Oscar AI clinical training platform, OTC ENFit syringes for enteral medication delivery, and adjacent therapeutic devices including UroShield (catheter care) and PainShield (pain management).
Is ENvue Medical a public or private company?
ENvue Medical is a public company. It is classified as public and is currently operating.
When was ENvue Medical founded?
ENvue Medical was founded in 2017. It employs 11 to 50 people.
Where is ENvue Medical based?
ENvue Medical is headquartered in Arlington Heights, United States, in the North America region.
How does ENvue Medical make money?
Four revenue lines are on record. Feeding Tube Consumables are the primary driver. The others are capital Equipment Sales, AI Training Platform Subscription and OTC ENFit Syringes.
Who are ENvue Medical's main competitors?
AngioDynamics is listed as an emerging player. Broad incumbents are Stryker, Brainlab, Smiths Medical, Becton, Dickinson and Company (BD) and Medtronic. Direct peers are Avanos Medical and NeoMed. Others are Cardinal Health and Covis Pharma (Nutricia/Danone).
Does ENvue Medical have an API?
No public API is recorded for ENvue Medical.
What industry is ENvue Medical in?
ENvue Medical's product category is Enteral Feeding Tube Navigation Systems. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT). Its NAICS code is 339112 and its SIC code is 3841.